Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Gourapura J Renukaradhya"'
Autor:
Jennifer Schrock, Raksha Suresh, Olaitan Comfort Shekoni, Dina Bugybayeva, Sara Dolatyabi, Juliette Hanson, Frederick C Michel, Anne Dorrance, Gourapura J Renukaradhya
Publikováno v:
Journal of Applied Poultry Research, Vol 33, Iss 4, Pp 100496- (2024)
SUMMARY: Avian influenza has been a growing problem in the United States for decades. Low pathogenic avian influenza (LPAI) virus causes low morbidity, while highly pathogenic avian influenza (HPAI) has a devastating effect on the poultry industry ca
Externí odkaz:
https://doaj.org/article/7bafba9f7e5148f5834e309ccc339dac
Autor:
Aigerim Mailybayeva, Bolat Yespembetov, Sholpan Ryskeldinova, Nadezhda Zinina, Abylai Sansyzbay, Gourapura J Renukaradhya, Nikolai Petrovsky, Kaissar Tabynov
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186484 (2017)
We previously developed a potent candidate vaccine against bovine brucellosis caused by Brucella abortus using the influenza viral vector expressing Brucella Omp16 and L7/L12 proteins (Flu-BA). Our success in the Flu-BA vaccine trial in cattle and re
Externí odkaz:
https://doaj.org/article/fa3d9ae76ed54046bcf48aa85db88ca5
Autor:
Mohamed Elaish, John M Ngunjiri, Ahmed Ali, Ming Xia, Mahmoud Ibrahim, Hyesun Jang, Jagadish Hiremath, Santosh Dhakal, Yosra A Helmy, Xi Jiang, Gourapura J Renukaradhya, Chang-Won Lee
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171174 (2017)
The current inactivated influenza vaccines provide satisfactory protection against homologous viruses but limited cross-protection against antigenically divergent strains. Consequently, there is a need to develop more broadly protective vaccines. The
Externí odkaz:
https://doaj.org/article/d68f1e00333948a285cfd46c5d100992
Autor:
Jagadish Hiremath, Kyung-il Kang, Ming Xia, Mohamed Elaish, Basavaraj Binjawadagi, Kang Ouyang, Santosh Dhakal, Jesus Arcos, Jordi B Torrelles, X Jiang, Chang Won Lee, Gourapura J Renukaradhya
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0151922 (2016)
Pigs are believed to be one of the important sources of emerging human and swine influenza viruses (SwIV). Influenza virus conserved peptides have the potential to elicit cross-protective immune response, but without the help of potent adjuvant and d
Externí odkaz:
https://doaj.org/article/6a6a5185522c40718ad60dfb47cb2ca8
Autor:
Kang Ouyang, Shireen A Woodiga, Varun Dwivedi, Carolyn M Buckwalter, Anirudh K Singh, Basavaraj Binjawadagi, Jagadish Hiremath, Cordelia Manickam, Rose Schleappi, Mahesh Khatri, Jianmin Wu, Samantha J King, Gourapura J Renukaradhya
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90066 (2014)
Influenza A virus (IAV) and Streptococcus pneumoniae (pneumococcus) are two major upper respiratory tract pathogens responsible for exacerbated disease in coinfected individuals. Despite several studies showing increased susceptibility to secondary b
Externí odkaz:
https://doaj.org/article/4b00123842694db7b09de0a7a459f550
Autor:
Varun Dwivedi, Cordelia Manickam, Basavaraj Binjawadagi, Dechamma Joyappa, Gourapura J Renukaradhya
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51794 (2012)
Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. In this study, we illustrated the efficacy of nanoparticle-entrapped UV-killed virus vaccine against an economically important respiratory viral
Externí odkaz:
https://doaj.org/article/74d5ceb224454eaca3f84ab6e5c941f0
Autor:
Gabriela Mansano do Nascimento, Dina Bugybayeva, Veerupaxagouda Patil, Jennifer Schrock, Ganesh Yadagiri, Gourapura J. Renukaradhya, Diego G. Diel
Publikováno v:
Viruses; Volume 15; Issue 4; Pages: 994
Influenza A viruses (IAV-S) belonging to the H1 subtype are endemic in swine worldwide. Antigenic drift and antigenic shift lead to a substantial antigenic diversity in circulating IAV-S strains. As a result, the most commonly used vaccines based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c45607e6ccb0a8607574026249edc5f
Autor:
Thomas, Milton, Wang, Zhao, Sreenivasan, Chithra C., Hause, Ben M., Gourapura J. Renukaradhya, Li, Feng, Francis, David H., Kaushik, Radhey S., Khatri, Mahesh
Publikováno v:
In Vaccine 15 January 2015 33(4):542-548
Autor:
Patricia A. Boley, Carolyn M. Lee, Jennifer Schrock, Kush Kumar Yadav, Veerupaxagouda Patil, Raksha Suresh, Songqing Lu, Maoqi Mark Feng, Juliette Hanson, Rudra Channappanavar, Scott P. Kenney, Gourapura J. Renukaradhya
Publikováno v:
Journal of Nanobiotechnology. 21
Background Unlike the injectable vaccines, intranasal lipid nanoparticle (NP)-based adjuvanted vaccine is promising to protect against local infection and viral transmission. Infection of ferrets with SARS-CoV-2 results in typical respiratory disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e67b18e6987b709bbdddda8b97774966
https://doi.org/10.1186/s12951-023-01816-3
https://doi.org/10.1186/s12951-023-01816-3
Autor:
Meruert Babayeva, Kairat Tabynov, Tair Nurpeisov, Gleb Fomin, Gourapura J. Renukaradhya, Nikolai Petrovsky, Kaissar Tabynov
Publikováno v:
Frontiers in Immunology. 13
Allergic rhinitis is an important risk factor for bronchial asthma. Allergen-specific immunotherapy (ASIT) is the gold standard for treatment of allergic rhinitis, conjunctivitis, and asthma. A disadvantage of current ASIT methods is the length of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4031e790091b319175cf23b638809e8f
https://doi.org/10.3389/fimmu.2022.983621
https://doi.org/10.3389/fimmu.2022.983621